Literature DB >> 29681775

Does ITV vaginal procedure ensure dosimetric coverage during IMRT of post-operative gynaecological tumours without instructions concerning rectal filling?

Ramona Verges1, Alexandra Giraldo1, Alejandro Seoane2, Elisabet Toral1, M Carmen Ruiz1, Ariadna Pons1, Jordi Giralt1.   

Abstract

AIM: To find out whether the internal target volume (ITV) vaginal procedure ensures dosimetric coverage during intensity-modulated radiation therapy (IMRT) of post-operative gynaecological tumours without instructions on rectal filling.
BACKGROUND: The ITV vaginal procedure does not necessarily include all movements of the bladder, and does not include changes in the rectal volume. We should know if the vaginal ITV is a useful tool in maintaining CTV coverage during treatment.
MATERIALS AND METHODS: A retrospective analysis of 24 patients treated between July 2012 and July 2014 with adjuvant IMRT for gynaecological cancer. All patients underwent empty and full bladder CT on simulation (CT-planning) and three weeks later (CT-control). ITV displacement was measured and the 3D vector was calculated. ITV coverage was then evaluated by comparing the volume covered by the prescription isodose on both CT's. Patients were asked to have full bladder but they did not follow recommendations for the rectum.
RESULTS: The mean 3D vector was 0.64 ± 0.32 cm (0.09-1.30). The mean ITV coverage loss was 5.8 ± 5.7% (0-20.2). We found a significant positive correlation between the 3D vector and the loss of coverage (Pearson correlation, r = 0.493, 95% CI: 0.111-0.748, p = 0.0144). We did not find any significant correlation between the bladder and rectal parameters with the 3D vector and loss of dosimetric coverage. We found a trend between the maximum rectal diameter in CT-planning and 3D vector (r = 0.400, 95% CI: -0.004 to 0.692, p = 0.0529).
CONCLUSION: ITV vaginal procedure contributed to ensuring a good dose coverage without instructions on rectal filling.

Entities:  

Keywords:  Bladder filling; ITV coverage; Organ motion; Rectal filling; Vaginal ITV

Year:  2018        PMID: 29681775      PMCID: PMC5906863          DOI: 10.1016/j.rpor.2018.01.006

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  22 in total

1.  ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up.

Authors:  Nicoletta Colombo; Carien Creutzberg; Frederic Amant; Tjalling Bosse; Antonio González-Martín; Jonathan Ledermann; Christian Marth; Remi Nout; Denis Querleu; Mansoor Raza Mirza; Cristiana Sessa
Journal:  Radiother Oncol       Date:  2015-12-09       Impact factor: 6.280

2.  Quantification of vaginal motion associated with daily endorectal balloon placement during whole pelvis radiotherapy for gynecologic cancers.

Authors:  Nicolette Taku; Joseph Dise; Owen Kenton; Lingshu Yin; Boon-Keng Kevin Teo; Lilie L Lin
Journal:  Radiother Oncol       Date:  2016-05-28       Impact factor: 6.280

3.  Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies.

Authors:  Arno J Mundt; Anthony E Lujan; Jacob Rotmensch; Steven E Waggoner; S Diane Yamada; Gini Fleming; John C Roeske
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-04-01       Impact factor: 7.038

4.  A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418.

Authors:  Anuja Jhingran; Kathryn Winter; Lorraine Portelance; Brigitte Miller; Mohammad Salehpour; Rakesh Gaur; Luis Souhami; William Small; Lawrence Berk; David Gaffney
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-28       Impact factor: 7.038

5.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

Authors:  W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

6.  Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.

Authors:  Michael R Folkert; Karin K Shih; Nadeem R Abu-Rustum; Elizabeth Jewell; Marisa A Kollmeier; Vicky Makker; Richard R Barakat; Kaled M Alektiar
Journal:  Gynecol Oncol       Date:  2012-11-15       Impact factor: 5.482

7.  Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy.

Authors:  Arno J Mundt; Loren K Mell; John C Roeske
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-08-01       Impact factor: 7.038

8.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.

Authors:  William Small; Loren K Mell; Penny Anderson; Carien Creutzberg; Jennifer De Los Santos; David Gaffney; Anuja Jhingran; Lorraine Portelance; Tracey Schefter; Revathy Iyer; Mahesh Varia; Kathryn Winter; Arno J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-26       Impact factor: 7.038

9.  Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer.

Authors:  Karin K Shih; Sarah A Milgrom; Nadeem R Abu-Rustum; Marisa A Kollmeier; Ginger J Gardner; William P Tew; Richard R Barakat; Kaled M Alektiar
Journal:  Gynecol Oncol       Date:  2012-11-20       Impact factor: 5.482

10.  A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy.

Authors:  John C Roeske; Dacian Bonta; Loren K Mell; Anthony E Lujan; Arno J Mundt
Journal:  Radiother Oncol       Date:  2003-11       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.